Health Care: Drugs

SciClone Pharmaceuticals (SCLN: NASDAQ)

$4.82 0.05 | 1.05%
05/23/13 - 02:49 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 156.27M 133.64M 85.11M 72.41M
Cost of Sales 21.19M 19.54M 12.14M 11.43M
Gross Operating Profit 135.08M 114.10M 72.98M 60.98M
Selling, General, and Administrative Expenses 91.77M 72.89M 37.61M 31.33M
Research & Development 6.14M 12.35M 12.42M 16.53M
Operating Income before D & A (EBITDA) 37.16M 28.87M 22.95M 13.12M
Depreciation & Amortization 3.45M 2.94M 556.00K 530.00K
Interest Income 89.00K 71.00K 105.00K 153.00K
Other Income - Net -42.00K 3.47M 953.00K 18.00K
Special Income / Charges -27.31M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 6.46M 29.48M 23.45M 12.76M
Interest Expense 185.00K 213.00K 195.00K 179.00K
Pre-Tax Income 6.27M 29.26M 23.26M 12.59M
Income Taxes -3.35M 798.00K 2.18M 641.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 9.62M 0.00 21.08M 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 9.62M 0.00 21.08M 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 9.62M 28.46M 21.08M 11.94M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 36.93M 0.00 21.08M 0.00
Preferred Dividends
Net Income Available To Common 9.62M 0.00 21.08M 0.00
Basic EPS from Continuing Ops. 0.17 0.52 0.44 0.26
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.17 0.52 0.44 0.26
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.17 0.52 0.44 0.26
Basic Normalized Net Income/Share 0.65 n.a. 0.44 n.a.
EPS fr Continuing Ops. 0.16 0.50 0.43 0.25
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.16 0.50 0.43 0.25
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.16 0.50 0.43 0.25
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 0.61 n.a. 0.43 n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SCLN

View All

Latest SCLN Headlines from TheStreet

More Financial News for SCLN

Press Releases for SCLN

See All Press Releases

Partner Headlines for SCLN

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter